P/B
4
GSK
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
$94.2B
Market Cap • 10/5/2026
1999
(27 years)
Founded
1976
(50 years ago)
IPO
NYSE
Listing Exchange
United Kingdom
Country
Valuation
P/S
2,1
P/EBITDA
10,9
P/OCF
8,5
P/FCF
10,3
P/E
14,8
BVPS
11,6
EPS
3,2
Market Cap
Market Cap
94,2B
EV
114,2B
EV/Revenue
2,6
EV/EBITDA
13,2
EV/EBIT
13,2
Payout
Dividend Per Share
1,8
Dividend Yield
3,8%
Buyback Yield
1,7%
Total Yield
5,4%
Dividend Yield 5Y
3,7%
Payout
54,7%
Retained Earnings
15,2B
Profitability
Gross Margin
72,7%
EBITDA Margin
19,5%
EBIT Margin
19,5%
Net Margin
15,9%
D&A/EBITDA
0%
R&D/Revenue
27,7%
Capex/Revenue
4,3%
Capex/D&A
0%
Capex/OCF
17,2%
SBC/OCF
—
% PPE
16,2%
% Goodwill
12%
ROE
33,1%
ROIC
12,4%
Growth
CAGR Revenue 5Y
3%
CAGR Op. Income 5Y
3,5%
CAGR Net Income 5Y
3,3%
CAGR EPS 5Y
1,4%
CAGR OCF 5Y
3,8%
Leverage
N.D./EBITDA
2,3
Debt/Equity
0%
Current Ratio
0,8
Quick Ratio
0,5
Interest Coverage
919,4%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!